Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.

Last week, readers were most interested in a story about the conviction of lab owner, formerly an NFL player, for genetic testing fraud.

BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.

The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.

The certification covers assays for pertussis, malaria, chlamydia, gonorrhea, herpes, cytomegalovirus, and group B streptococcus.

The company will begin sales of the test in a small number of community oncology centers and expand to dozens of practices before full commercial launch next year.

Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.